Vimarsana
Biggest News Aggregation in the World

Industry Approach News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Industry Approach. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Industry Approach Today - Breaking & Trending Today

Global Advanced High Strength Steel Market to Reach $50.96 Billion by 2028: Driven by Increasing Product Applications in Automotive and Construction Industries - Vimarsana News

Global Advanced High Strength Steel Market to Reach $50.96 Billion by 2028: Driven by Increasing Product Applications in Automotive and Construction Industries

/PRNewswire/ -- The "Global Advanced High Strength Steel Market (2023-2028) by Grade, End-User, and Geography, Competitive Analysis, Impact of Economic...

Uber Regains Its "Moral Compass" and Establishes a Safety Culture After Tragedy Shakes Its AV Ambitions | by Phillip Wilcox | The Startup | Mar, 2021 - Vimarsana News

Uber Regains Its "Moral Compass" and Establishes a Safety Culture After Tragedy Shakes Its AV Ambitions | by Phillip Wilcox | The Startup | Mar, 2021

After my book The Future is Autonomous launched, Uber sold the Advanced Technologies Group responsible for the testing and deployment of its autonomous vehicle fleet for a $400 million investment in start-up Aurora Innovation, Inc. on December 7, 2020. However, the steps that Uber took to create a “safety culture” and the emphasis it placed on creating a standard for the industry to test autonomous vehicles is still relevant and important. The “Fleits” financial model could also still be an option for companies seeking to create a ride-hailing “robotaxi” fleet. ...

Source: medium.com
InMed Pharmaceuticals to Participate in 2021 Cannabinoid-Derived Pharmaceuticals Industry Review Summit Europe - Vimarsana News

InMed Pharmaceuticals to Participate in 2021 Cannabinoid-Derived Pharmaceuticals Industry Review Summit Europe

VANCOUVER, BC, Jan. 19, 2021 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (NASDAQ:INM) (TSX:IN), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the clinical development of cannabinol ("CBN"), today announced that executives of the Company will speak at the 2021 Cannabinoid-Derived Pharmaceuticals Industry Review Summit Europe ("CDP Europe"). CDP Europe will be held virtually from January 19-21, 2021. Michael Woudenberg - Vice President, Chemistry, Manufacturing & Controls, Karen Long - Senior...